A peptide from the honeybee’s sting tore through aggressive cancer cells in a laboratory dish within an hour — and the headline went around the world. Here’s what the research actually found, why the leap from the lab is so hard, and what bee-sting therapy has cost some people.
Similar Posts
Hoxsey therapy
A family herbal formula, a coal miner turned showman, the largest alternative cancer operation in mid-century America, and the one libel case the medical establishment lost. Here is the whole story, including the parts both sides leave out.
The Rife machine and frequency devices
A San Diego inventor, a microscope said to see what no one else could, a frequency for every disease, and a story of suppression that has outlived him by fifty years. Here is the Rife machine's whole story, told from both sides.
Essiac and Flor-Essence
A small-town Ontario nurse, a recipe said to come from an Ojibwa healer, a free clinic, a bill that fell a few votes short — and fifty years of argument. The full story of Essiac, told from both sides.
Ivermectin, fenbendazole and mebendazole: what’s behind the cancer buzz
Three worm medicines have become some of the most talked-about names in cancer circles. Here’s where the interest comes from, what the trials show so far, and how to raise it with your oncologist.
Laetrile (amygdalin, “vitamin B17”)
In the 1970s, tens of thousands of Americans sought out a compound made from apricot pits, state legislatures voted to allow it, and the fight reached the US Supreme Court. This is the full story of laetrile — the case its supporters made, the case against it, and why it still comes up today.
The Burzynski antineoplaston story
A Polish-trained doctor, a family of compounds first found in blood and urine, decades of trials, two federal criminal trials and a medical-board case. Why does this story still divide people?
